Blueprint Medicines Corp buy BiotechBee
Start price
07.09.22
/
60%
€74.46
Target price
31.12.24
€100.00
Performance (%)
-29.49%
End price
05.05.23
€52.50
Summary
This prediction ended on 05.05.23 with a price of €52.50. The price of Blueprint Medicines Corp has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.49%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % | 49,60 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % | 80,87 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % | 60,37 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % | 60,00 % |
According to BiotechBee what are the pros and cons of Blueprint Medicines Corp for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Blueprint Medicines Corp diskutieren
Buy mit Kursziel 100,0